GlassScriptPhysician profile
Arthur D Jung
NPI 1730281577
$49,866.39
in general payments reported to CMS, 2019-2025
23 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $76.39 · 2021: $3,902 · 2022: $15K · 2023: $17K · 2024: $11K · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $5,333 · Travel and Lodging: $2,843 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,035 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,827.50 |
| Food and Beverage | $5,333.41 |
| Travel and Lodging | $2,842.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,035.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $43,034.61 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $1,352.38 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Topcon Healthcare, INC. | $1,000.00 | 2023 | |
| Sun Pharmaceutical Industries INC. | $891.87 | 2019-2025 | Cequa, Xelpros |
| Abbvie INC. | $602.64 | 2022-2025 | |
| Alcon Vision LLC | $487.60 | 2019-2025 | Precision 1, Tryptyr, Precision7 |
| Harrow Eye, LLC | $450.25 | 2024-2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $342.21 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $287.26 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $220.34 | 2022-2023 | Tyrvaya |
| Coopervision INC. | $206.16 | 2019-2025 | Misight Contact Lens, Synergeyes Contact Lens |
| Aerie Pharmaceuticals, INC. | $144.46 | 2019 | |
| Sight Sciences, INC. | $138.92 | 2022-2023 | Tearcare System |
| Dompe US, INC. | $128.97 | 2022-2025 | Oxervate |
| Allergan, INC. | $112.57 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $107.90 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $68.32 | 2019-2023 | Tobradex St |
| Optos, INC. | $65.22 | 2019 | |
| Shire North American Group INC | $62.02 | 2019 | |
| Biotissue Holdings INC. | $58.30 | 2021 | |
| Kala Pharmaceuticals, INC. | $42.22 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $37.94 | 2022 | |
| Leadiant Biosciences, INC. | $24.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Jung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.